Company Search:
Advanced Search
Sponsored Links
Financiere de Tubize SA Company Snapshot
Financiere de Tubize SA operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Financiere de Tubize SA with three other pharmaceutical manufacturers in Europe: 4d Pharma Plc of the United Kingdom (2012 sales of £20,000.00 [US$27,322.40 ] ), Cytotools Ag of Germany (50,000.00 Euro [US$60,679.50 ] of which 100% was Licence Fees), and Norda ASA which is based in Norway (645,000.00 Norwegian Kroner [US$80,979.75 ] of which 100% was Infectious Diseases).

Sales Analysis. Financiere de Tubize SA reported sales of 37,000.00 Euro (US$44.90 thousand) for the year ending December of 2012. This represents a sharp decrease of 54.3% versus 2011, when the company's sales were 81,000.00 Euro.
  Stock Performance Chart for Financiere de Tubize SA
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 66.80
(Figures in Euro)
1 Week 0.1%   13 Weeks 7.1%  
4 Weeks 12.8%   52 Weeks 7.1%  
Financiere de Tubize SA Key Data:
  Ticker: TUB Country: Belgium
  Exchanges: BRU Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2012 Sales 37,000
(Year Ending Jan 2013).
Employees: 1
  Currency: Euro Market Cap: 2,586,505,085
  Fiscal Yr Ends: December Shares Outstanding: 38,720,136
  Share Type: Actions Ordinaires Closely Held Shares: 25,284,363
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.